Accolade Inc. (ACCD): Price and Financial Metrics

Accolade Inc. (ACCD): $10.25

0.24 (-2.29%)

POWR Rating

Component Grades








Add ACCD to Watchlist
Sign Up

Industry: Internet




#38 of 51

in industry

ACCD Price/Volume Stats

Current price $10.25 52-week high $17.00
Prev. close $10.49 52-week low $6.33
Day low $10.18 Volume 974,000
Day high $10.78 Avg. volume 819,966
50-day MA $12.12 Dividend yield N/A
200-day MA $11.39 Market Cap 793.43M

ACCD Stock Price Chart Interactive Chart >


  • ACCD scores best on the Growth dimension, with a Growth rank ahead of 76.56% of US stocks.
  • The strongest trend for ACCD is in Growth, which has been heading up over the past 26 weeks.
  • ACCD ranks lowest in Sentiment; there it ranks in the 15th percentile.

ACCD Stock Summary

  • ACCD's went public 3.51 years ago, making it older than just 15% of listed US stocks we're tracking.
  • In terms of twelve month growth in earnings before interest and taxes, ACCOLADE INC is reporting a growth rate of -63.31%; that's higher than merely 20.83% of US stocks.
  • The volatility of ACCOLADE INC's share price is greater than that of 77.43% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to ACCOLADE INC, a group of peers worth examining would be BFLY, HCAT, RELY, QTWO, and PHR.
  • ACCD's SEC filings can be seen here. And to visit ACCOLADE INC's official web site, go to

ACCD Valuation Summary

  • ACCD's EV/EBIT ratio is -6.5; this is 144.52% lower than that of the median Healthcare stock.
  • Over the past 42 months, ACCD's price/sales ratio has gone down 8.1.

Below are key valuation metrics over time for ACCD.

Stock Date P/S P/B P/E EV/EBIT
ACCD 2023-12-29 2.4 2.1 -6.5 -6.5
ACCD 2023-12-28 2.6 2.2 -6.9 -6.9
ACCD 2023-12-27 2.5 2.2 -6.7 -6.7
ACCD 2023-12-26 2.4 2.1 -6.5 -6.5
ACCD 2023-12-22 2.3 2.0 -6.3 -6.3
ACCD 2023-12-21 2.3 2.0 -6.1 -6.1

ACCD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ACCD has a Quality Grade of D, ranking ahead of 16.91% of graded US stocks.
  • ACCD's asset turnover comes in at 0.297 -- ranking 433rd of 561 Business Services stocks.
  • 500 - Internal server error

The table below shows ACCD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-08-31 0.297 0.433 -2.101
2021-05-31 0.369 0.447 -2.074
2021-02-28 0.512 0.450 2.793
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310
2020-02-28 1.906 0.444 3.310

ACCD Price Target

For more insight on analysts targets of ACCD, see our ACCD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $63.00 Average Broker Recommendation 1.18 (Strong Buy)

Accolade Inc. (ACCD) Company Bio

Accolade, Inc. is an emerging growth company, which engages in the provision of personalized, technology-enabled solutions through a technology platform. It offers Accolade Total Benefits and Accolade Total Care. Accolade Total Benefits focuses on member benefits engagement and Accolade Total Care help guides members to healthcare providers. The company was founded by Thomas K. Spann and J. Michael Cline in 2007 and is headquartered in Seattle, WA.

ACCD Latest News Stream

Event/Time News Detail
Loading, please wait...

ACCD Latest Social Stream

Loading social stream, please wait...

View Full ACCD Social Stream

Latest ACCD News From Around the Web

Below are the latest news stories about ACCOLADE INC that investors may wish to consider to help them evaluate ACCD as an investment opportunity.

Market Participants Recognise Accolade, Inc.'s (NASDAQ:ACCD) Revenues Pushing Shares 30% Higher

Accolade, Inc. ( NASDAQ:ACCD ) shareholders are no doubt pleased to see that the share price has bounced 30% in the...

Yahoo | December 18, 2023

Accolade to Announce Fiscal Third Quarter 2024 Financial Results

SEATTLE, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal third quarter 2024 financial results on Monday, January 8, 2024, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details To Listen via Telephone: Pre-registration is required by the conference call operator. Please pre-register by clicking here (

Yahoo | December 11, 2023

Is Accolade (ACCD) Stock Outpacing Its Business Services Peers This Year?

Here is how Accolade (ACCD) and Adecco SA (AHEXY) have performed compared to their sector so far this year.

Yahoo | December 5, 2023

Accolade To Present at Piper Sandler 35th Annual Healthcare Conference

SEATTLE, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will be presenting at the Piper Sandler 35th Annual Healthcare Conference in New York on Wednesday, November 29, 2023 at 10:00 am ET. A webcast of the company’s fireside chat will be available at and a replay will be available for 90 days. About Accolade, Inc. Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that prov

Yahoo | November 27, 2023

Accolade Announces Repurchase of $76.5 Million of 0.50% Convertible Senior Notes Due 2026

SEATTLE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it has entered into separate, privately negotiated transactions with certain holders of its outstanding 0.50% Convertible Senior Notes due 2026 (the “Notes”) to repurchase (the “Repurchases”) approximately $76.5 million aggregate principal amount of the Notes for an aggregate cash repurchase price of approximately $65.8 million. “We are strategically improving our net cash position and strengthening our

Yahoo | November 16, 2023

Read More 'ACCD' Stories Here

ACCD Price Returns

1-mo -9.45%
3-mo 13.13%
6-mo -25.24%
1-year -17.14%
3-year -77.99%
5-year N/A
YTD -14.65%
2023 54.17%
2022 -70.45%
2021 -39.40%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!